Prime Therapeutics named Mostafa Kamal CEO to succeed retiring Ken Paulus


Prime Therapeutics, one of the largest privately held companies in Minnesota, has appointed Mostafa Kamal as CEO as Ken Paulus heads into retirement.

Previous How a Peninsula biotech turned its psoriasis drugs into a $2.4 billion acquisition
Next Labcorp spinoff Fortrea launches as $3B public company with 19K employees in Durham